Benzinga | Nov 10, 2021 04:47PM EST

TELA Bio Q3 EPS $(0.57) Misses $(0.52) Estimate, Sales $7.70M Beat $7.55M Estimate

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.52) by 9.62 percent. This is a 7.55 percent decrease over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $7.70 million which beat the analyst consensus estimate of $7.55 million by 1.99 percent. This is a 44.93 percent increase over sales of $5.31 million the same period last year.